Are you need IT Support Engineer? Free Consultant
Report ID: HC0036
Pages: 198
Base Year: 2023
Format: PDF
Historical Date: 2019-2022
MARKET SCOPE:
The global Newborn and Prenatal Genetic Testing market is projected to grow significantly, registering a CAGR of 11.5% during the forecast period (2024 – 2032).
Prenatal testing is a crucial aspect of monitoring your baby’s health, aiming to identify any potential issues that might impact the well-being of the fetus, including genetic defects and congenital conditions. While some prenatal tests are recommended by doctors, only a select group of women may require specialized screening examinations. Concurrently, newborn testing is conducted to identify abnormalities that could lead to specific health conditions, particularly inborn genetic defects. The screening process for genetic diseases in newborns encompasses conditions such as Down syndrome, phenylketonuria, homocystinuria, among others. Consequently, the early diagnosis of genetic diseases during pregnancy and within the initial 24 hours of a newborn’s birth holds significant importance.
Prenatal genetic testing is conducted during pregnancy to diagnose diseases or detect specific genetic abnormalities, typically before the 8 to 10 weeks of gestation, and it aids in determining the fetus’s gender. The majority of prenatal genetic tests utilize a blood sample from the expectant mother for various screening procedures. Diagnostic methods, known for their higher effectiveness and accuracy, are the preferred choice for detecting chromosome abnormalities compared to screening methods. The growth of the global prenatal and newborn genetic testing market is attributed to factors such as the rising prevalence of genetic diseases among infants, governmental support promoting the use of prenatal and newborn testing, and an increase in birth rates.
MARKET OVERVIEW:
Driver: High number of genetic diseases patients in infants is driving the market growth.
The increased occurrence of genetic diseases in infants has contributed significantly to the expansion of the prenatal testing and newborn screening market. As per the World Health Organization’s classification, genetic diseases encompass various conditions like Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease. Sickle cell anemia, for instance, affects millions worldwide and is notably prevalent among individuals with ancestry from Africa, America, Cuba, Central America, Saudi Arabia, and India. A report from November 2021, as per the National Center for Biotechnology Information, revealed that genetic illnesses were identified in 9.4% of pediatric patients, with 44.7% of these cases observed in critically ill newborns. This heightened prevalence of genetic diseases in infants has spurred the demand, contributing to the growth of the prenatal testing and newborn screening market.
Opportunities: Rising birth rate globally is expected to pave the way for market growth in the upcoming years.
The upsurge in the birth rate is anticipated to drive the expansion of the prenatal testing and newborn screening market. The birth rate, or natality, denotes the total number of live human births per 1,000 population within a specific period, divided by the length of that period in years. Prenatal testing plays a crucial role in evaluating fetal health before birth, while newborn screening tests identify certain medical conditions in infants shortly after birth, facilitating early intervention if necessary. For example, in May 2022, as reported by the Centers for Disease Control and Prevention, a US-based national public health agency, there was a 1% increase in births in 2021, totaling 3,659,289. The general fertility rate reached 56.6 births per 1,000 women aged 15-44, reflecting a 1% rise from the figures in 2020. Consequently, the surge in the birth rate contributes to the overall growth of the prenatal testing and newborn screening market.
COVID IMPACT:
The onset of the COVID-19 pandemic has caused significant disruptions in healthcare workflows worldwide. The disease has compelled numerous industries, including various healthcare sub-domains, to temporarily suspend operations. The global prenatal and newborn genetic testing market faced a downturn in 2020 due to the global economic downturn triggered by COVID-19. Furthermore, the pandemic disrupted the supply chain across diverse end-user industries, including healthcare, food & beverage, and industrial sectors. However, the market is expected to undergo recovery in 2021, displaying steady growth in the prenatal and newborn genetic testing market in the foreseeable future. This rebound is credited to the increased adoption of novel screening methods, particularly in developing countries such as China and India.
SEGMENTATION ANALYSIS:
The consumable segment is anticipated to grow significantly during the forecast period.
The consumables segment held the largest market share in Prenatal and Newborn Genetic Testing, driven by an increase in the number of pregnant women and a surge in newborn screening for genetic testing. Notably, approximately 4 million babies undergo screening annually in the U.S., as reported by Healthy Moms. Strong Babies. On the other hand, the diagnostic segment is experiencing the fastest growth during the forecast period, propelled by the growing adoption of prenatal and newborn testing in developing countries.
The hospital segment is anticipated to grow significantly during the forecast period.
In 2022, the hospital segment secured the largest market share, attributed to the presence of qualified medical staff, enabling enhanced services for patients, particularly in the diagnosis and treatment of neuromuscular diseases, including genetic abnormalities. Hospitals play a pivotal role in delivering superior patient services. Conversely, diagnostic centers are projected to exhibit the highest growth rate in the forecast period. This is primarily due to these centers offering comprehensive pre-pregnancy and prenatal services, reducing the potential for complications during pregnancy.
REGIONAL ANALYSIS:
The North American region is set to witness significant growth during the forecast period.
In 2022, North America emerged as the frontrunner in the prenatal and newborn genetic testing market and is expected to sustain its leadership throughout the forecast period. This is attributed to the robust presence of major players like Abbott Laboratories, PerkinElmer Inc., and Mettler Toledo, coupled with advancements in PCR diagnostic methods. The market in this region is further fueled by the growing number of expectant women opting for genetic screening. Additionally, factors such as high purchasing power and increasing awareness about various inherited genetic diseases are poised to propel market growth. Notably, World Down Syndrome Day is annually observed on March 21, aiming to raise awareness about the diagnosis and treatment of individuals with Down syndrome.
COMPETITIVE ANALYSIS
The global Newborn and Prenatal Genetic Testing market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.
Scope of the Report
** In – depth qualitative analysis will be provided in the final report subject to market
Primary and Secondary Research
In order to understand the market in detail we conduct primary and secondary research. We collect as much information as we can from the market experts through primary research. We contact the experts from both demand and supply side and conduct interviews to understand the actual market scenario. In secondary research, we study and gather the data from various secondary sources such as company annual reports, press releases, whitepapers, paid databases, journals, and many other online sources. With the help of the primary interviews, we validate the data collected from secondary sources and get a deep understanding on the subject matter. Post this our team uses statistical tools to analyses the data to arrive at a conclusion and draft it in presentable manner.
Market Size Estimations
Understanding and presenting the data collected is a crucial task. Market sizing is a critical part of the data analysis and this task is performed by using Top-down and bottom-up approaches. In this process, we place different data points, market information and industry trends at a suitable space. This placement helps us presume the estimated & forecast values for coming few years. We use several mathematical and statistical models to estimate the market sizes of different countries and segments. Each of this is further added up to outline the total market. These approaches are individually done on regional/country and segment level.
Data Triangulation
As we arrive at the total market sizes, the market is again broken down into segments and subsegments. This process is called as data triangulation and is implementable wherever applicable. This step not only helps us conclude the overall market engineering process, but also gives an assurance on accuracy of the data generated. The data is triangulated based on studying the market trends, various growth factors, and aspects of both demand and supply side.